共 50 条
- [4] EFFICACY OF DUTASTERIDE ON BENIGN PROSTATIC HYPERPLASIA ENDPOINTS IN THE REDUCTION BY DUTASTERIDE OF PROSTATE CANCER EVENTS (REDUCE) STUDY ACCORDING TO BASELINE INTERNATIONAL PROSTATE SYMPTOM SCORE AND PROSTATE VOLUME [J]. JOURNAL OF UROLOGY, 2010, 183 (04): : E691 - E691
- [5] DUTASTERIDE REDUCES PROSTATITIS SYMPTOMS COMPARED TO PLACEBO IN MEN ENROLLED IN THE REDUCE (REDUCTION BY DUTASTERIDE OF PROSTATE CANCER EVENTS) STUDY [J]. JOURNAL OF UROLOGY, 2010, 183 (04): : E311 - E312
- [7] EVALUATION OF SAFETY AND ABILITY OF DUTASTERIDE TO IMPROVE URINARY PARAMETERS IN SUBJECTS WITH LOW TESTOSTERONE IN THE REDUCTION BY DUTASTERIDE IN PROSTATE CANCER EVENTS (REDUCE) STUDY [J]. JOURNAL OF UROLOGY, 2013, 189 (04): : E564 - E565
- [9] Chemoprevention of prostate cancer in men at high risk: Rationale and design of the reduction by dutasteride of prostate cancer events (reduce) trial [J]. JOURNAL OF UROLOGY, 2004, 172 (04): : 1314 - 1317